HAEM4:Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN): Difference between revisions
Bailey.Glen (talk | contribs) Created page with "==Primary Author(s)*== Linsheng Zhang, MD, PhD __TOC__ ==Graphical Data Links== '''MDS, MDS/MPN and MPN Tables''' - A comprehensive list of copy number alterations and CN-..." |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 13: | Line 13: | ||
==General Disease Overview / Description of Cancer Category== | ==General Disease Overview / Description of Cancer Category== | ||
The MDS/MPNs include a category of myeloid malignancies with overlapping characteristics of myelodysplastic syndrome ([[Myelodysplastic Syndromes (MDS)|MDS]]) and myeloproliferative neoplasm ([[Myeloproliferative Neoplasms (MPN)|MPN]]) at the time of initial presentation (disease onset). | The MDS/MPNs include a category of myeloid malignancies with overlapping characteristics of myelodysplastic syndrome ([[HAEM4:Myelodysplastic Syndromes (MDS)|MDS]]) and myeloproliferative neoplasm ([[HAEM4:Myeloproliferative Neoplasms (MPN)|MPN]]) at the time of initial presentation (disease onset). | ||
==WHO Classification Pages (Includes Links to Content)== | ==WHO Classification Pages (Includes Links to Content)== | ||
*[[Chronic | *[[HAEM5:Chronic myelomonocytic leukaemia]] | ||
*[[ | *[[HAEM5:Myelodysplastic/myeloproliferative neoplasm with neutrophilia]] | ||
*[[Juvenile | *[[HAEM5:Juvenile myelomonocytic leukaemia]] | ||
*[[Myelodysplastic/ | *[[HAEM5:Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]] | ||
*[[Myelodysplastic/ | *[[HAEM5:Myelodysplastic/myeloproliferative neoplasm, NOS|MDS/MPN, Unclassifiable]] | ||
==Other Related Pages (Includes Links to Content)== | ==Other Related Pages (Includes Links to Content)== | ||
| Line 40: | Line 40: | ||
#Previously diagnosed MPN developed cytopenia(s): classification must be based on initial presentation; avoid “reclassification”. | #Previously diagnosed MPN developed cytopenia(s): classification must be based on initial presentation; avoid “reclassification”. | ||
#Cases with well-defined fusions that can be classified otherwise: ''[[Chronic | #Cases with well-defined fusions that can be classified otherwise: ''[[HAEM5:Chronic myeloid leukaemia|BCR-ABL1]]''; fusion involving ''[[HAEM5:Myeloid/lymphoid neoplasm with PDGFRA rearrangement|PDGFRA]], [[HAEM5:Myeloid/lymphoid neoplasm with PDGFRB rearrangement|PDGFRB]]'', or ''[[HAEM5:Myeloid/lymphoid neoplasm with FGFR1 rearrangement|FGFR1]]''; or ''[[HAEM5:Myeloid/lymphoid neoplasm with JAK2 rearrangement|PCM1-JAK2]]''. | ||
==References== | ==References== | ||